Skip to main content
User menu
Subscribe
Donate
The HIV Treatment Journal of
Webinars
Current Issue
Drug Guides
Trending
COVID-19 and HIV
HIV Decriminalization
Hepatitis C
U=U
HIV & Aging
HIV Basics
HIV Cure Research
HIV Prevention
HIV Treatment
Stigma & Discrimination
POZ Advocate
Archive
About
Who We Are
Advertise
Contact
Subscribe
Reader/Customer Service
News
Donate
Donate
Bulk Subscriber Donation
Search
10 Years of the U=U campaign: Where it’s succeeded—and fallen short
Being Bridgette: Community and clinicians meet
Biktarvy is among the 15 drugs facing Medicare price negotiations
Back to top
Search
How Trump’s PEPFAR restrictions threaten the HIV global response
A demand for bodily autonomy—and data privacy—for people with HIV
What Black social workers must say and do about HIV
A referral is not a strategy for aging with HIV
Drug pricing is HIV policy
Will Medicaid’s new work requirements exempt people with HIV?
CDC’s vaccine committee undermined by its new governing rules, medical groups…
PrEP use hits record level as progress begins to slow
Social influences of health
Gilead seeks FDA approval for the first once-weekly pill for HIV prevention
Pagination
First page
« First
Previous page
‹‹
…
Page
2
Current page
3
Page
4
Page
5
…
Next page
››
Last page
Last »